(Q28250526)

English

Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments

scientific article

Cartilage Oligomeric Matrix Protein Level in Rheumatic Diseases: Potential Use as a Marker for Measuring Articular Cartilage Damage and/or the Therapeutic Efficacy of Treatments

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments (English)

0 references

Cartilage Oligomeric Matrix Protein Level in Rheumatic Diseases: Potential Use as a Marker for Measuring Articular Cartilage Damage and/or the Therapeutic Efficacy of Treatments (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

object named as

Mauro Galeazzi

0 references

author name string

Gabriella Morozzi

1

0 references

Marta Fabbroni

2

0 references

Francesca Bellisai

3

0 references

Gabriella Pucci

4

0 references

G. MOROZZI

1

0 references

M. FABBRONI

2

0 references

F. BELLISAI

3

0 references

G. PUCCI

4

0 references

M. GALEAZZI

5

0 references

language of work or name

0 references

publication date

June 2007

0 references

1 June 2007

0 references

Annals of the New York Academy of Sciences

0 references

1108

0 references

1

0 references

398-407

0 references

Evidence for sequential appearance of cartilage matrix proteins in developing mouse limbs and in cultures of mouse mesenchymal cells

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in relation to collagen fibrils in the equine tendon

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Identification of cartilage oligomeric matrix protein (COMP) gene mutations in patients with pseudoachondroplasia and multiple epiphyseal dysplasia

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Biomarkers for diagnosing and monitoring autoimmune diseases

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Matrix metalloproteinases: role in arthritis

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Prognostic laboratory markers of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Remission in rheumatoid arthritis: wishful thinking or clinical reality?

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.041

21 January 2018

Identifiers

10.1196/ANNALS.1422.041

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28250526&oldid=1979155868"